A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model

NCT04105959 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Response

Interventions

DRUG: RIST4721
DRUG: Placebo

Sponsor

Aristea Therapeutics, Inc.